Clinical trials: IO-resistant sqNSCLC, open to volunteers
IO-resistant sqNSCLC
A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer
Lung cancer is one of the most common forms of cancer. One common type is non-small cell lung cancer (NSCLC). NSCLC happens when abnormal cells in the lungs grow too fast. This can stop the lungs from working normally.
- Trial name
- MarsLight-11 (NCT07217301)
- Testing
- TAK-928, Control Arm
- Where
- 46 sites in United States, China and 1 more
- Volunteers
- 600 people
- Sponsor
- Takeda